Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study

Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis

Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization data

Plasma amyloid-beta oligomer is related to subjective cognitive decline and brain amyloid status